Pediatric Neurology
Volume 43, Issue 1 , Pages 17-20 , July 2010

Complications of Antipsychotic Therapy in Children With Tourette Syndrome

  • Tamara Pringsheim, MD

      Affiliations

    • Department of Clinical Neurosciences and Pediatrics, University of Calgary, Calgary, Alberta, Canada
    • Corresponding Author InformationCommunications should be addressed to: Dr. Pringsheim; Calgary Tourette Syndrome Clinic; 2888 Shaganappi Trail NW; Calgary, Alberta T3B 6A8, Canada.
    • ,
  • Michelle Pearce, MD

      Affiliations

    • Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada

Received 1 December 2009 ,Accepted 8 February 2010.

References 

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000;
  2. Freeman RD, Fast DK, Burd L, Kerbeshian J, Robertson MM, Sandor P. An international perspective on Tourette syndrome: Selected findings from 3500 individuals in 22 countries. Dev Med Child Neurol. 2000;42:436–447
  3. Scahill L, Erenberg G, Berlin CM, et al. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx. 2006;3:192–206
  4. Fedorowicz V, Fombonne E. Metabolic side effects of atypical antipsychotics in children: A literature review. J Psychopharmacol. 2005;19:533–550
  5. Fraguas D, Merchan-Naranjo J, Laita P, Parellada M, Moreno D. Metabolic and hormonal side effects in children and adolescents treated with second generation antipsychotics. J Clin Psychiatry. 2008;69:1166–1175
  6. McIntyre R, Jerrell J. Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. Arch Pediatr Adolesc Med. 2008;162:929–935
  7. Correll C, Manu P, Olshansky V, Napolitano B, Kane J, Malhotra A. Cardiometabolic risk of second generation antipsychotic medications during first time use in children and adolescents. JAMA. 2009;302:1765–1773
  8. Sethi K, Morgan J. Drug-induced movement disorders. In:  Jankovic J,  Tolosa E editor. Parkinson's disease and movement disorders. Philadelphia: Lippincott Williams and Wilkins; 2007;p. 394–408
  9. Leucht S, Corves C, Arbter D, Engel R, Li C. Second generation versus first generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet. 2009;373:31–41
  10. Pierre J. Extrapyramidal symptoms with atypical antipsychotics. Drug Saf. 2005;28:191–208
  11. American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89:525–584
  12. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008;32(Suppl.):S1–201
  13. Lambert M, Delvin E, Levy E, O'Loughlin J, Paradis G. Prevalence of cardiometabolic risk factors by weight status in a population based sample of Quebec children and adolescents. Can J Cardiol. 2008;24:575–583
  14. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: Methods and development. Vital Health Stat. 2002;246:1–190
  15. Dai S, Fulton J, Harrist R, Grunbaum J, Steffen L, Labarthe D. Blood lipids in children: Age related patterns and association with body-fat indices. Am J Prev Med. 2009;37(Suppl):S56–S64
  16. Mattson N, Ronnemaa T, Juonala M, Viikari J, Raitakari O. Childhood predictors of the metabolic syndrome in adulthood. The Cardiovascular Risk in Young Finns Study. Ann Med. 2008;40:542–552
  17. Al Mamun A, Cramb S, O'Callaghan M, William G, Najman J. Childhood overweight status predicts diabetes at age 21 years: A follow-up study. Obesity. 2009;17:1255–1261
  18. Juonala M, Jarvisalo M, Maki-Torkko N, Kahonen M, Viikari J, Raitakari O. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood. Circulation. 2005;112:1486–1493
  19. Pulkki-Raback L, Elovainio M, Kivimaki M, Mattson N, Raitakairi O. Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study. Health Psychol. 2009;28:108–116
  20. Daniels SR, Greer FR. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198–208

PII: S0887-8994(10)00092-5

doi: 10.1016/j.pediatrneurol.2010.02.012

Pediatric Neurology
Volume 43, Issue 1 , Pages 17-20 , July 2010

Article Tools